These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11339503)

  • 21. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
    Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P
    J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
    Deekonda S; Rankin D; Davis P; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4148-52. PubMed ID: 26316468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
    Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
    Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold.
    Dziadulewicz EK; Brown MC; Dunstan AR; Lee W; Said NB; Garratt PJ
    Bioorg Med Chem Lett; 1999 Feb; 9(3):463-8. PubMed ID: 10091703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.
    Stadnicki A; DeLa Cadena RA; Sartor RB; Bender D; Kettner CA; Rath HC; Adam A; Colman RW
    Dig Dis Sci; 1996 May; 41(5):912-20. PubMed ID: 8625762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
    Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
    Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Campos MM; Henriques MG; Calixto JB
    Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
    Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
    Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of inflammation by kininogen deficiency in a rat model of inflammatory arthritis.
    Sainz IM; Isordia-Salas I; Castaneda JL; Agelan A; Liu B; DeLa Cadena RA; Pixley RA; Adam A; Sartor RB; Colman RW
    Arthritis Rheum; 2005 Aug; 52(8):2549-52. PubMed ID: 16059911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
    Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
    Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.
    Sharif NA; Katoli P; Kelly CR; Li L; Xu S; Wang Y; Klekar L; Earnest D; Yacoub S; Hamilton G; Jacobson N; Shepard AR; Ellis D
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):21-34. PubMed ID: 24236827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins.
    Wu BJ; Ong KL; Shrestha S; Chen K; Tabet F; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):543-51. PubMed ID: 24357062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.
    Souza DG; Pinho V; Pesquero JL; Lomez ES; Poole S; Juliano L; Correa A; de A Castro MS; Teixeira MM
    Br J Pharmacol; 2003 May; 139(1):129-39. PubMed ID: 12746231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel-associated acute pain syndrome in mice.
    Zanata GC; Pinto LG; da Silva NR; Lopes AHP; de Oliveira FFB; Schivo IRS; Cunha FQ; McNaughton P; Cunha TM; Silva RL
    Eur J Pain; 2021 Jan; 25(1):189-198. PubMed ID: 32965065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury.
    Görlach C; Hortobágyi T; Hortobágyi S; Benyó Z; Relton J; Whalley ET; Wahl M
    J Neurotrauma; 2001 Aug; 18(8):833-8. PubMed ID: 11526989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
    Brechter AB; Lerner UH
    Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.
    Cunha TM; Verri WA; Fukada SY; Guerrero AT; Santodomingo-Garzón T; Poole S; Parada CA; Ferreira SH; Cunha FQ
    Eur J Pharmacol; 2007 Nov; 573(1-3):221-9. PubMed ID: 17669394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.